Benign cystic nephroma

Summary

Benign cystic nephroma (MONDO:0002385) is a disease and 3 clinical trials. A subtype of kidney benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	benign cystic nephroma
Mondo ID	MONDO:0002385
DOID	DOID:2673
NCIT	C7504
UMLS	C1266138
MedGen	220422
Is cancer (heuristic)	no

Also known as: benign cystic nephroma · benign multilocular cystic nephroma · cystic nephroma

Disease family

This is a subtype of kidney benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › benign urinary system neoplasm › kidney benign neoplasm › benign cystic nephroma

Related subtypes (11): kidney lipoma, renal adenoma, nephrogenic adenofibroma, kidney oncocytoma, nephrogenic adenoma, kidney angiomyolipoma, renal leiomyoma, benign metanephric tumor, benign neoplasm of renal pelvis, benign mesonephroma, nephroma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01247597	Not specified	RECRUITING	DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
NCT03382158	Not specified	RECRUITING	International PPB/DICER1 Registry
NCT00565903	Not specified	COMPLETED	Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome